Table 1 A multivariable linear regression model investigating factors associated with self-perceived health EQ VAS presented as adjusted estimates and 95% confidence interval (CI), n = 931

From: Health outcomes in hospitalised and non-hospitalised individuals after COVID-19, an observational, cross-sectional study

 

Estimate

95% CI

p value

Intercept

58.23

−35.51 to 152.98

0.23

mMRC ≥2

−6.83

−9.63 to −4.03

2.34e-06

6MWT ratio

11.66

4.53 to 18.79

0.001

Symptoms (number)

−0.65

−0.95 to −0.36

1.78e-05

Sick leave

−0.08

−0.11 to −0.04

1.63e-05

PHQ-9 depression ≥10

−7.11

−10.11 to −4.12

4.75-e06

FSS fatigue ( ≥ 4)

−5.48

−9.04 to −1.91

0.003

MoCA cognitive impairment (<26)

−3.30

−5.94 to −0.66

0.02

Age

−0.03

−0.15 to 0.08

0.59

Level of care (hospitalised)

8.34

4.07 to 12.61

0.0001

Sex (male)

2.15

−1.50 to 5.80

0.25

Follow-up

−0.003

−0.01 to 0.004

0.41

  1. All analyses were adjusted for age, level of care (not hospitalised vs hospitalised), sex, and days of follow-up. Ordinal and continuous variables were categorised based on predefined clinical cut-offs: mMRC ≥2 indicates a clinically significant dyspnoea. PHQ-9 ≥ 10 indicates a clinical depression; FSS ≥ 4 indicates fatigue. MoCA <26 indicates cognitive impairment. mMRC the modified Medical Research Council dyspnoea scale. 6MWT ratio Six-Minute Walking Test ratio. PHQ-9 the Patient Health Questionnaire-9, FSS Fatigue Severity Scale, MoCA Montreal Cognitive Assessment test.
Back to article page